Technology and outcomes assessment in lung transplantation

Proceedings of the American Thoracic Society

Volumn 6, Issue 1, 2009, Pages 128-136

  Yusen, Roger D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung transplantation; Outcomes assessment (health care); Quality of life; Survival analysis; Technology assessment (biomedical)

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; BRONCHIOLITIS OBLITERANS; GRAFT SURVIVAL; HEALTH CARE SYSTEM; HUMAN; LUNG TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW;

HUMANS; LUNG TRANSPLANTATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SURVIVAL ANALYSIS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 58549114398     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200809-102GO     Document Type: Review

References (84)

1. Littenberg B. Technology assessment. Acad Med 1992;67:424-428.
2. Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007;357:2143-2152.
3. Sweet SC, Aurora P, Benden C, Wong JY, Goldfarb SB, Elidemir O, Woo MS, Mallory GB Jr; International Pediatric Lung Transplant Collaborative. Lung transplantation and survival in children with cystic fibrosis: solid statistics-flawed interpretation. Pediatr Transplant 2008;12:129-136.
4. Department of Health and Human Services. 2007 OPTN/SRTR Annual Report: Transplant Data 1997-2006. http://www.ustransplant.org/annual-reports/current/ 113-surv-new-dh.htm (Date accessed August 31, 2008).
5. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the international society for heart and lung transplantation: twenty-fourth official adult lung and heart-lung transplant report-2004. J Heart Lung Transplant 2007;26:782-795.
6. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, Egan T, Keshavjee S, Knoop C, Kotloff R, et al.; Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-755.
7. United Network for Organ Sharing. Lung Allocation System Calculator. http://www.unos.org/resources/frm-LAS-Calculator.asp?index=96 (Date accessed August 31, 2008).
8. Department of Health and Human Services, 2005 OPTN/SRTR Annual Report: Analytical Methods and Database Design: Implications for Transplant Researchers. http://www.ustransplant.org/annual-reports/archives/2005/chapter-x-AR-cd.htm (Date accessed August 31, 2008).
9. Department of Health and Human Services. 2007 OPTN/SRTR Annual Report: Transplant Data 1997-2006. Technical Notes and Analytic Methods. http://www.ustransplant.org/annual-reports/current/Tech-Notes-AR-CD.htm (Date accessed August 31, 2008).
10. Dickinson DM, Ellison MD, Webb RL. Data sources and structure. Am J Transplant 2003;3:13-28.
11. Dickinson DM, Bryant PC, Williams MC, Levine GN, Li S, Welch JC, Keck BM, Webb RL. Transplant data: sources, collection, and caveats. Am J Transplant 2004;4:13-26.
12. Dickinson DM, Dykstra DM, Levine GN, Li S, Welch JC, Webb RL. Transplant data: sources, collection and research considerations, 2004. Am J Transplant 2005;5:850-856.
13. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995;107:187S-193S.
14. World Health Organization, WHOQOL. Measuring Quality of Life. http://www.who.int/mental-health/media/68.pdf (Date accessed August 31, 2008).
15. WHOQOL group. Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 1993;2:153-159.
16. Department of Health and Human Services. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. http://www.fda.gov/cder/guidance/5460dft.pdf (Date accessed August 31, 2008).
17. von Neumann J, Morgenstern O. Theory of games and economic behavior, 3rd ed. New York: Wiley; 1953.
18. Nease RF Jr, Kneeland T, O'Connor GT, Sumner W, Lumpkins C, Shaw L, Pryor D, Sox HC. Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. JAMA 1995;273:1185-1190.
19. Yusen RD. What outcomes should be measured in patients with COPD? Chest 2001;119:327-328.
20. Yusen RD, Brown KL, Habrock TE, Sumner W, Nease RF, Patterson GA, Trulock EP, Littenberg B. The impact of lung transplantation on quality of life in patients with COPD. J Heart Lung Transplant 2005;24:S156-S157.
21. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
22. Kaplan R, Atkins C, Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis 1984;37:85-95.
23. Nord E, Pinto JL, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999;8:25-39.
24. Dolan P. Whose preferences count? Med Decis Making 1999;19:482-486.
25. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-1258.
26. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26:1229-1242.
27. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D, Working ISHLT. Group on primary lung graft dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1454-1459.
28. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz MI, Mallory GB, Snell GI, Yousem SA. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
29. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-27.
30. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001;20:518-524.
31. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226-232.
32. Yusen RD, Littenberg B. Integrating survival and quality of life data in clinical trials of lung disease. Chest 2005;127:1094-1096.
33. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
34. Ramsey S, Patrick D, Lewis S, Albert R, Raghu G. Improvement in quality of life after lung transplantation: a preliminary study. J Heart Lung Transplant 1995;14:870-877.
35. Gartner SH, Sevick MA, Keenan RJ, Chen GJ. Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant 1997;16:1129-1134.
36. Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, TenVergert EM. Cost-effectiveness of lung transplantation in the Netherlands. A scenario analysis. Chest 1998;113:124-130.
37. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax 2001;56:218-222.
38. Vasiliadis HM, Collet JP, Penrod JR, Ferraro P, Poirier C. A cost-effectiveness and cost-utility study of lung transplantation. J Heart Lung Transplant 2005;24:1275-1278.
39. Busschbach JJ, Horikx PE, van den Bosch JM, Brutel de la Rivière A, de Charro FT. Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest 1994;105:911-917.
40. Squier HC, Ries AL, Kaplan RM, Prewitt LM, Smith CM, Kriett JM, Jamieson SW. Quality of well-being predicts survival in lung transplantation candidates. Am J Respir Crit Care Med 1995;152:2032-2036.
41. van Enckevort PJ, TenVergert EM, Bonsel GJ, Geertsma A, van der Bij W, de Boer WJ, Koopmanschap MA, Al MJ, Rutten FF. Technology assessment of the Dutch lung transplantation program. Int J Technol Assess Health Care 1998;14:344-356.
42. Yusen RD, Littenberg B, Brown K, Herbstman D, Sumner W, Nease RF, Biggar DG, Pohl MS, Davis GE, Lefrak SS, et al. Validity of a computer-based patient preference instrument for assessing quality of life in COPD. Am J Respir Crit Care Med 1999;159:A815.
43. Singer LG, Gould MK, Glidden DV, Theodore J. Effect of lung transplantation on quality-adjusted survival in emphysema. J Heart Lung Transplant 2002;21:154.
44. Singer LG, Theodore J. Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates. Med Decis Making 2003;23:435-440.
45. Lobo FS, Gross CR, Matthees BJ. Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients. Qual Life Res 2004;13:377-388.
46. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE; National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003;348:2092-2102.
47. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345:1075-1083.
48. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82:431-443.
49. Lubsen J, Kirwan BA. Combined endpoints: can we use them? Stat Med 2002;21:2959-2970.
50. Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006;354:141-150.
51. Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR. The impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2007;175:507-513.
52. Snell GI, Valentine VG, Vitulo P, Glanville AR, McGiffin DC, Loyd JE, Roman A, Aris R, Sole A, Hmissi A, et al. RAD B159 Study Group. Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial. Am J Transplant 2006;6:169-177.
53. Mulligan MS, Shearon TH, Weill D, Pagani FD, Moore J, Murray S. Heart and lung transplantation in the United States, 1997-2006. Am J Transplant 2008;8:977-987.
54. Liou TG, Adler FR, Cahill BC, Cox DR. Correction: lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2008;359:536.
55. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6:1212-1227.
56. Department of Health and Human Services. Organ procurement and transplantation network: Final rule. 1999; Federal Register 42 CFR: 56649-56661. http://unos.org/SharedContentDocuments/final-rule-1.pdf (Date accessed August 31, 2008).
57. Vega JD, Johnson MR. OPTN/UNOS Thoracic Organ Transplantation Committee Meeting Interim Report of March 10, 2008. http://www.optn.org/CommitteeReports/ interim-main-ThoracicOrganTransplantation Committee-5-1-2008-10-25.pdf (Date accessed August 31, 2008).
58. Edwards LB. Personal communication, September 2, 2008.
59. Gross CR, Savik K, Bolman RM, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest 1995;108:1587-1593.
60. Littlefield C, Abbey S, Fiducia D, Cardella C, Greig P, Levy G, Maurer J, Winton T. Quality of life following transplantation of the heart, liver, and lungs. Gen Hosp Psychiatry 1996;18:36S-47S.
61. Limbos MM, Chan CK, Kesten S. Quality of life in female lung transplant candidates and recipients. Chest 1997;112:1165-1174.
62. TenVergert EM, Essink-Bot ML, Geertsma A, van Enckevort PJ, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life. Chest 1998;113:358-364.
63. Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest 1998;113:633-644.
64. MacNaughton KL, Rodrigue JR, Cicale M, Staples EM. Health-related quality of life and symptom frequency before and after lung transplantation. Clin Transplant 1998;12:320-323.
65. Lanuza DM, McCabe M, Norton-Rosko M, Corliss JW, Garrity E. Symptom experiences of lung transplant recipients: comparisons across gender, pretransplantation diagnosis, and type of transplantation. Heart Lung 1999;28:429-437.
66. Lanuza DM, Lefaiver C, Mc Cabe M, Farcas GA, Garrity E Jr. Prospective study of functional status and quality of life before and after lung transplantation. Chest 2000;118:115-122.
67. Stavem K, Bjørtuft O, Lund MB, Kongshaug K, Geiran O, Boe J. Health-related quality of life in lung transplant candidates and recipients. Respiration 2000;67:159-165.
68. van Den Berg JW, Geertsma A, van Der BIJW, Koëter GH, de Boer WJ, Postma DS, TenVergert M. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med 2000;161:1937-1941.
69. Matthees BJ, Anantachoti P, Kreitzer MJ, Savik K, Hertz MI, Gross CR. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung 2001;30:258-268.
70. De Vito Dabbs A, Dew MA, Stilley CS, Manzetti J, Zullo T, McCurry KR, Kormos RL, Iacono A. Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant 2003;22:1268-1275.
71. Vermeulen KM, Groen H, van der Bij W, Erasmus ME, Koëter GH, TenVergert EM. The effect of bronchiolitis obliterans syndrome on health related quality of life. Clin Transplant 2004;18:377-383.
72. Gerbase MW, Spiliopoulos A, Rochat T, Archinard M, Nicod LP. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest 2005;128:1371-1378.
73. Kugler C, Fischer S, Gottlieb J, Welte T, Simon A, Haverich A, Strueber M. Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant 2005;24:2262-2268.
74. Rodrigue JR, Baz MA, Kanasky WF Jr, MacNaughton KL. Does lung transplantation improve health-related quality of life? The University of Florida experience. J Heart Lung Transplant 2005;24:755-763.
75. Smeritschnig B, Jaksch P, Kocher A, Seebacher G, Aigner C, Mazhar S, Klepetko W. Quality of life after lung transplantation: a cross-sectional study. J Heart Lung Transplant 2005;24:474-480.
76. Rodrigue JR, Baz MA. Are there sex differences in health-related quality of life after lung transplantation for chronic obstructive pulmonary disease? J Heart Lung Transplant 2006;25:120-125.
77. Girard F, Chouinard P, Boudreault D, Poirier C, Richard C, Ruel M, Ferraro P. Prevalence and impact of pain on the quality of life of lung transplant recipients: a prospective observational study. Chest 2006;130:1535-1540.
78. Vermuelen KM, van der Bij W, Erasmus ME, TenVergert EM. Long-term health-related quality of life after lung transplantation: different predictors for different dimensions. J Heart Lung Transplant 2007;26:188-193.
79. Gerbase MW, Soccal PM, Spiliopoulos A, Nicod LP, Rochat T. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome. J Heart Lung Transplant 2008;27:898-904.
80. Vermeulen KM, TenVergert EM, Verschuuren EA, Erasmus ME, van der Bij W. Pre-transplant quality of life does not predict survival after lung transplantation. J Heart Lung Transplant 2008;27:623-627.
81. Limbos MM, Joyce DP, Chan CK, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000;118:408-416.
82. Sumner W, Nease R, Littenberg B. Assessing the value of medical informatics. U-titer. A utility assessment tool. Med Decis Making 1991;11:327.
83. Sumner W, Nease R, Littenberg B. U-titer: A utility assessment tool. Proceedings of the Fifteenth Annual Symposium on Computer Applications in Medical Care. Washington, DC.; 1991. Pp. 710-715.
84. van Enckevort PJ, Koopmanschap MA, Tenvergert EM, Geertsma A, van derBij W, deBoer WJ, Rutten FF. Lifetime costs of lung transplantation: estimation of incremental costs. Health Econ 1997;6:479-489.